These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 9411594)

  • 21. Effects of histamine on Th1/Th2 cytokine balance.
    Packard KA; Khan MM
    Int Immunopharmacol; 2003 Jul; 3(7):909-20. PubMed ID: 12810348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of IFN-alpha on the expression of various TH2 cytokines in human CD4+ T cells.
    Shibuya H; Hirohata S
    J Allergy Clin Immunol; 2005 Jul; 116(1):205-12. PubMed ID: 15990796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice.
    Teixeira MM; Talvani A; Tafuri WL; Lukacs NW; Hellewell PG
    J Leukoc Biol; 2001 Mar; 69(3):353-60. PubMed ID: 11261781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide dose, affinity, and time of differentiation can contribute to the Th1/Th2 cytokine balance.
    Rogers PR; Croft M
    J Immunol; 1999 Aug; 163(3):1205-13. PubMed ID: 10415015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
    Schweitzer AN; Sharpe AH
    J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quercetin regulates Th1/Th2 balance in a murine model of asthma.
    Park HJ; Lee CM; Jung ID; Lee JS; Jeong YI; Chang JH; Chun SH; Kim MJ; Choi IW; Ahn SC; Shin YK; Yeom SR; Park YM
    Int Immunopharmacol; 2009 Mar; 9(3):261-7. PubMed ID: 19061976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism and regulation of IgE production in allergy].
    Kurasawa K; Iwamoto I
    Nihon Rinsho; 1996 Feb; 54(2):434-9. PubMed ID: 8838093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune modulation for treatment of allergic disease.
    Nguyen TH; Casale TB
    Immunol Rev; 2011 Jul; 242(1):258-71. PubMed ID: 21682751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
    Ciprandi G; Tosca MA; Marseglia GL
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.
    Becker Y
    Virus Genes; 2004 Jan; 28(1):5-18. PubMed ID: 14739648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms controlling the human immunoglobulin E response: new directions in the therapy of allergic diseases.
    Leung DY
    Pediatr Res; 1993 Jan; 33(1 Suppl):S56-61;discussion S61-2. PubMed ID: 8433876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Regulation of Ige synthesis and cytokines in selected allergic diseases].
    Michałkiewicz J; Nowacka K; Stachowski J; Gregorek H; Madaliński K
    Pediatr Pol; 1996 Jan; 71(1):47-56. PubMed ID: 8966067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T-cell subsets (Th1 versus Th2).
    Romagnani S
    Ann Allergy Asthma Immunol; 2000 Jul; 85(1):9-18; quiz 18, 21. PubMed ID: 10923599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy and immunological changes subjacent to egg oral immunotherapy.
    Perezábad L; Reche M; Valbuena T; López-Fandiño R; Molina E; López-Expósito I
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):504-9. PubMed ID: 25935429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ablation of ovomucoid-induced allergic response by desensitization with recombinant ovomucoid third domain in a murine model.
    Rupa P; Mine Y
    Clin Exp Immunol; 2006 Sep; 145(3):493-501. PubMed ID: 16907919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Th1/Th2 balance in systemic inflammatory response syndrome (SIRS)].
    Iwasaka H; Noguchi T
    Nihon Rinsho; 2004 Dec; 62(12):2237-43. PubMed ID: 15597790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Th1/Th2 concept--its importance for regulation of IgE].
    Haas H; Schlaak M
    Immun Infekt; 1994 Jun; 22(3):88-93. PubMed ID: 7927472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoregulation in allergy: the potential of anti-IgE antibodies of IL-4 antagonists for the treatment of allergic diseases.
    Heusser C
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):283-9; discussion 289-91. PubMed ID: 7873064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.